Derik De Bruin

Work

Analyst Derik De Bruin works at BAML and is focused on Healthcare, ´╗┐Basic Materials sectors with 361 price targets and ratings documented since 2012 spanning on 27 stocks. Analyst's average stock valuation to be materialised ratio is 80.09% with an average time for price targets to be met of 121.7 days.

Most recent stock forecast was given on TX, Ternium S.A at 23-Jan-2023.

Derik De Bruin best performing recommendations are on DNA.
The best stock recommendation documented was for DNA at 1/28/2022. The price target of $6 was fulfilled within 4 days with a profit of $1.03 (20.72%) receiving and performance score of 51.81.

Average potential price target upside

ILMN A AVTR BRKR DGX DNA GH HOLX IQV LH MTD MYGN PKI QGEN SEER TXG STVN TX CTLT DHR EXAS IDXX PSNL TLIS WAT WST ICLR

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

250

4 days ago

6/7 (85.71%)

$40.14 (14.27%)

178

Buy

300

$85.97 (40.17%)

330

12 days ago

0/10 (0%)

$147.93 (63.02%)

Buy

300

$85.97 (40.17%)

320

2 months 15 days ago

2/9 (22.22%)

$91.84 (39.00%)

123

Hold

225

$10.97 (5.13%)

240

2 months 22 days ago

3/5 (60%)

$49.92 (19.11%)

75

Hold

225

$10.97 (5.13%)

230

2 months 25 days ago

17/17 (100%)

$-7.03 (-0.65%)

209

Show more analysts
ILMN A AVTR BRKR DGX DNA GH HOLX IQV LH MTD MYGN PKI QGEN SEER TXG STVN TX CTLT DHR EXAS IDXX PSNL TLIS WAT WST ICLR